Interferon-γ antagonizes transforming growth factor-β2-mediated immunosuppression in murine toxoplasma encephalitis

Journal of Neuroimmunology

Volumn 81, Issue 1-2, 1998, Pages 38-48

  Schlüter, Dirk ^a   Bertsch, Daniela ^a   Frei, Karl ^b   Hübers, Simona B ^c   Wiestler, Otmar D ^c   Hof, Herbert ^a   Fontana, Adriano ^b   Deckert Schlüter, Martina ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Interferon ; Toxoplasma gondii; Transforming Growth Factor

Indexed keywords

RECOMBINANT GAMMA INTERFERON; TRANSFORMING GROWTH FACTOR BETA2;

ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; DOSE RESPONSE; DRUG EFFECT; ENCEPHALITIS; FEMALE; IMMUNOREGULATION; IMMUNOTHERAPY; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ANIMALS; CELL COUNT; DISEASE SUSCEPTIBILITY; FEMALE; FLOW CYTOMETRY; IMMUNE TOLERANCE; INTERFERON TYPE II; LYMPHOCYTE SUBSETS; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICROGLIA; RECOMBINANT FUSION PROTEINS; TOXOPLASMA; TOXOPLASMOSIS, CEREBRAL; TRANSFORMING GROWTH FACTOR BETA;

EID: 18744437901     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00156-2     Document Type: Article

References (42)

1. Barral-Netto M., Barral A., Brownell C.E., Skeiky Y.A.W., Ellingsworth L.R., Twardzik D.R., Reed S.G. Transforming growth factor-β in leishmanial infection: a parasite escape mechanism. Science. 257:1992;545-548.
2. Beller D.J., Kieley J.M., Unanue E.R. Regulation of macrophage populations. I. Preferential inductions of Ia-rich peritoneal exsudated by immunologic stimuli. J. Immunol. 124:1980;1426-1432.
3. Bermudez L.E., Covaro G., Remington J.S. Infection of murine macrophages with Toxoplasma gondii is associated with release of transforming growth factor-β and downregulation of expression of tumor necrosis factor receptors. Infect. Immun. 61:1993;4126-4130.
4. 1 suppresses acute and chronic arthritis in experimental animals. J. Clin. Invest. 87:1991;1108.
5. Brown C.R., Hunter C.A., Esters R.G., Beckman E., Forman J., David C., Remington J.S., McLeod R. Definitive identification of a gene that confers resistance against Toxoplasma cyst burden and encephalitis. Immunology. 85:1995;419-428.
6. Chantry D., Turner M., Abney E., Feldman M. Modulation of cytokine production by transforming growth factor-β J. Immunol. 142:1989;295-4295.
7. Chao C.C., Anderson W.R., Hu S., Gekker G., Martella A., Peterson P.K. Activated microglia inhibit multiplication of Toxoplasma gondii via a nitric oxide mechanism. Clin. Immunol. Immunopathol. 67:1993;178-183.
8. Czarniecki L.W., Chiu H.H., Wong G.H.W., McCabe S.M., Palladino M.A. Transforming growth factor-β modulates the expression of class II histocompatibility antigens on human cells. J. Immunol. 140:1988;4217-4223.
9. Deckert-Schlüter M., Schlüter D., Schmidt D., Schwendemann G., Wiestler O.D., Hof H. Toxplasma encephalitis in congenic B10 and BALB mice: impact of genetic factors on the immune response. Infect. Immun. 62:1994;221-228.
10. Deckert-Schlüter M., Albrecht S., Hof H., Wiestler O.D., Schlüter D. Dynamics of the intracerebral and splenic cytokine mRNA production in Toxoplasma gondii-resistant and -susceptible congenic strains of mice. Immunology. 85:1995;408-418.
11. Deckert-Schlüter M., Rang A., Weiner D., Huang S., Wiestler O.D., Hof H., Schlüter D. Interferon-γ-receptor-deficiency renders mice highly susceptible to toxoplasmosis by decreased macrophage activation. Lab. Invest. 75:1996;827-841.
12. 3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-γ J. Immunol. 145:1990;940-944.
13. Dubois C.M., Ruscetti F.W., Palaszywski E.W., Falk L.A., Oppenheim J.J., Keller J.R. Transforming growth factor β is a potent inhibitor of interleukin 1 (IL-1) receptor expression: proposed mechanism of inhibition of IL-1 action. J. Exp. Med. 172:1990;737-744.
14. 1) and recombinant human tumor necrosis factor-α reciprocally regulate the generation of lymphokine-activated killer cell activity. J. Immunol. 140:1988;2312-2316.
15. Fontana A., Frei K., Bodmer S., Hofer E., Schreier M., Palladino M.A., Zinkernagel R.M. Transforming growth factor-β inhibits the generation of cytotoxic T cells in virus-infected mice. J. Immunol. 143:1989;3230-3234.
16. Frei K., Siepl C., Großcurth P., Bodmer S., Schwerdel C., Fontana A. Antigen presentation and tumor cytotoxicity by interferon-gamma-treated microglial cells. Eur. J. Immunol. 17:1987;1271-1278.
17. + T lymphocytes is required to reactive chronic infection with Toxoplasma gondii. J. Immunol. 149:1992;175-180.
18. Gazzinelli R.T., Oswald I.P., Hieny S., James S.L., Sher A. The microbicidal activity of interferon-γ-treated macrophages against Trypanosoma cruzi involves an L-arginin-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-β Eur. J. Immunol. 22:1992;2501-2506.
19. Gazzinelli R.T., Eltoum I., Wynn T.A., Sher A. Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-a and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation. J. Immunol. 150:1993;3672-3681.
20. Graham R.C., Karnovsky M.J.J. The early stages of absorption of injected horseradish peroxidase in the proximal tubules of mouse kidney: ultrastructural cytochemistry by a new technique. Histochem. Cytochem. 14:1966;291-302.
21. Hunter C.A., Roberts C.W., Alexander J. Kinetic of cytokine mRNA production in the brains of mice with progressive toxoplasmic encephalitis. Eur. J. Immunol. 22:1992;2317-2322.
22. Hunter C.A., Litton M.J., Remington J.S., Abrams J.S. Immunocytochemical detection of cytokines in the lymph nodes and brains of mice resistant or susceptible to toxoplasmic encephalitis. J. Inf. Dis. 170:1994;939-945.
23. Hunter C.A., Bermudez L., Beerwick H., Waegel W., Remington J.S. Transforming growth factor-β inhibits interleukin-12-induced production of interferon-γ by natural killer cells: a role for transforming growth factor-β in the regulation of T cell-independent resistance to Toxoplasma gondii. Eur. J. Immunol. 25:1995;994-1000.
24. Kehrl J.H., Wakefield L.M., Roberts A.B., Jakowlew S., Alvarez-Mon M., Derynck R., Sporn M.B., Fauci A.S. Production of transforming growth factor-β by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med. 163:1986;1037-1050.
25. Langermans J.A.M., van der Hulst M.E.B., Nibbering P.H., Hiemstra P.S., Fransen L., van Furth R. IFN-gamma induced L-arginine dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-alpha. J. Immunol. 148:1992;568-574.
26. Lee G., Ellingsworth L.R., Gillis S., Wall R., Kincade P.W. β-transforming growth factors are potential regulators of B lymphopoiesis. J. Exp. Med. 166:1987;1290-1299.
27. 1. J. Immunol. 146:1991;1849-1857.
28. Oswald I.P., Gazzinelli R.T., Sher A., James S.L. IL-10 synergizes with IL-4 and transforming growth factor-β to inhibit macrophage cytotoxic activity. J. Immunol. 148:1992;3578-3582.
29. 1 of expression and function of the receptor for IFN-γ on mouse macrophages. J. Immunol. 149:1992;2028-2034.
30. 1. J. Immunol. 146:1991;3012-3017.
31. Ranges G.E., Figari L.S., Espevik T., Palladino M.A. Inhibition of cytotoxic T cell development by transforming growth factor-β and reversal by recombinant tumor necrosis factor-α J. Exp. Med. 166:1987;991-998.
32. Schlüter D., Löhler J., Deckert M., Hof H., Schwendemann G. Toxoplasma encephalitis of immunocompetent and nude mice: immunohistochemical characterisation of Toxoplasma antigen, infiltrates and major histocompatibility products. J. Neuroimmunol. 31:1991;185-198.
33. + T cells in murine Listeria monocytogenes meningoencephalitis. Eur. J. Immunol. 25:1995;2384-2391.
34. Schlüter D., Kaefer N., Hof H., Wiestler O.D., Deckert-Schlüter M. Expression pattern and cellular origin of cytokines in the normal and Toxoplasma gondii-infected murine brain. Am. J. Pathol. 150:1997;1021-1035.
35. Sedgwick J., Schwender S., Imrich H., Dörries R., Butcher G.W., terMeulen V. Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system. Proc. Natl. Acad. Sci. USA. 88:1991;7438-7443.
36. Sher A., Oswald I., Hieny S., Gazzinelli R.T. Toxoplasma gondii induces a T-independent IFN-gamma response in natural killer cells that requires both adherent accessory cells and tumor necrosis factor-a. J.Immunol. 150:1993;3982-3989.
37. 1 gene results in multifocal inflammatory disease. Nature. 359:1992;693-699.
38. Stitz L., Planz O., Bilzer T., Frei K., Fontana A. Transforming growth factor-β modulates T cell-mediated encephalitis caused by Borna disease virus. J. Immunol. 147:1991;3581-3586.
39. + T cells in mice. J. Immunol. 140:1988;3943-3946.
40. Suzuki Y., Orellana M.A., Schreiber R.D., Remington J.S. Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. Science. 240:1988;516-518.
41. Suzumura A., Sawada M., Yamamoto H., Marunouchi T. Transforming growth factor-β suppresses activation and proliferation of microglia in vitro. J. Immunol. 151:1993;2150-2158.
42. Tsunawaki S., Sporu M., Ding A., Nathan C. Deactivation of macrophages by transforming growth factor-β Nature. 334:1988;260-262.